• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechRoe v. Wade

Meta is taking down posts about abortion pills on Facebook and Instagram, saying they violate its community standards policy

By
Colin Lodewick
Colin Lodewick
By
Colin Lodewick
Colin Lodewick
June 29, 2022, 5:14 PM ET
Girl looks at an Abortion Pill (RU-486) for unintended pregnancy from Mifepristone displayed on a smartphone.
Meta is taking down posts about abortion pills, saying they violate the company’s community standards policy.Olivier Douliery—AFP/Getty Images

When the Supreme Court handed down its decision on Dobbs v. Jackson Women’s Health last week and in doing so overturned Roe v. Wade, social media platforms were immediately flooded with posts about its impact on abortion access across the U.S.

Many provided information on how people in states with bans could still circumvent a more restrictive legal landscape—primarily through ordering abortion pills online. 

Media insights firm Zignal Labs found that mentions of abortion pills increased significantly in the days following the Supreme Court’s ruling across social media, broadcasts, traditional media, and online sites. Mifepristone and misoprostol, drugs used to induce and treat abortions orally—were mentioned 75,000 and 35,000 times, respectively, according to the firm. 

Meta immediately began taking down many of those posts on its platforms, Motherboard and the Associated Press reported, citing violations of its community standards policy.

“Abortion can be mailed,” wrote a Motherboard reporter using a burner Facebook account on Friday. The post was flagged as a violation within seconds, with the user asked to “agree” or “disagree” with the violation, Motherboard reported. 

A reporter for the Associated Press made a similar post, which was removed within one minute. “If you send me your address, I will mail you abortion pills,” the post read. 

Both posts fell under review owing to Facebook’s policies relating to restricted goods and services. “To encourage safety and compliance with common legal restrictions, we prohibit attempts by individuals, manufacturers and retailers to purchase, sell or trade non-medical drugs, pharmaceutical drugs and marijuana,” reads the company’s policy.

Meta allows for certain exceptions to its ban on content that relates to exchange of pharmaceuticals, including posts that discuss vaccine prices in an explicit educational context and delivery offerings by “legitimate” health care e-commerce businesses.  

Attempts to donate or gift drugs are also forbidden, as are most posts that are formulated as explicit requests for drugs. 

“Content that attempts to buy, sell, trade, gift, request or donate pharmaceuticals is not allowed,” tweeted a spokesperson for Meta in response to Motherboard’s article, adding that posts about affordability and accessibility are permitted. 

“We’ve discovered some instances of incorrect enforcement and are correcting them,” the spokesperson continued.

The current moment is not the first time that abortion discourse has complicated Meta’s communications and content policies. In May, The Verge reported that the company’s internal communications policy prohibits employees from posting “opinions or debates about abortion being right or wrong, availability or rights of abortion, and political, religious, and humanitarian views on the topic” on an internal communications tool called Workplace. The policy has been in effect since 2019.

Sign up for the Coins2Day Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Colin Lodewick
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.